ATM expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.139000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.395200E-01
Normal-vs-Stage2
4.176600E-01
Normal-vs-Stage3
3.474200E-01
Normal-vs-Stage4
4.324000E-01
Stage1-vs-Stage2
7.075600E-01
Stage1-vs-Stage3
6.987700E-02
Stage1-vs-Stage4
8.987600E-01
Stage2-vs-Stage3
5.600400E-03
Stage2-vs-Stage4
8.462600E-01
Stage3-vs-Stage4
8.361800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.168000E-01
Normal-vs-AfricanAmerican
4.358600E-01
Normal-vs-Asian
3.616800E-01
Caucasian-vs-AfricanAmerican
7.338800E-01
Caucasian-vs-Asian
1.157030E-01
AfricanAmerican-vs-Asian
6.416400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.011400E-01
Normal-vs-Female
4.313200E-01
Male-vs-Female
1.076370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.216600E-01
Normal-vs-Age(41-60Yrs)
4.363000E-01
Normal-vs-Age(61-80Yrs)
4.065000E-01
Normal-vs-Age(81-100Yrs)
3.871600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.958400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.648800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.790200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.533850E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.253000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.039800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.157800E-01
Normal-vs-Daily Drinker
3.874200E-01
Normal-vs-Weekly Drinker
3.861200E-01
Normal-vs-Occasional Drinker
3.894800E-01
Normal-vs-Social Drinker
4.472600E-01
Non Drinker-vs-Daily Drinker
3.556000E-01
Non Drinker-vs-Weekly Drinker
3.586600E-01
Non Drinker-vs-Occasional Drinker
4.097200E-01
Non Drinker-vs-Social Drinker
5.172600E-01
Daily Drinker-vs-Weekly Drinker
9.532400E-01
Daily Drinker-vs-Occasional Drinker
9.344000E-01
Daily Drinker-vs-Social Drinker
1.702010E-01
Weekly Drinker-vs-Occasional Drinker
8.962400E-01
Weekly Drinker-vs-Social Drinker
1.717590E-01
Occasional Drinker-vs-Social Drinker
1.935580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.393000E-01
Normal-vs-Grade 2
1.101360E-01
Normal-vs-Grade 3
8.514300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.903800E-01
Grade 1-vs-Grade 3
9.221400E-01
Grade 1-vs-Grade 4
3.393000E-01
Grade 2-vs-Grade 3
8.365800E-01
Grade 2-vs-Grade 4
1.101360E-01
Grade 3-vs-Grade 4
8.514300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.167800E-01
Normal-vs-NonDiabetic
3.974600E-01
Diabetic-vs-NonDiabetic
4.037400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.070000E-01
Normal-vs-NoPancreatitis
4.050200E-01
Pancreatitis-vs-NoPancreatitis
9.624000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.179200E-01
Normal-vs-N1
4.149000E-01
N0-vs-N1
9.111600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.811200E-01
Normal-vs-TP53-NonMutant
4.240800E-01
TP53-Mutant-vs-TP53-NonMutant
9.991800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
